Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Pfizer drug gets speedy FDA review for rare heart failure complication
Tafamidis chalked up a comprehensive win in its phase III trials programme
Bluebird bags breakthrough status for CALD gene therapy
News comes after impressive data from a phase II/III trial
Daily Brief: AstraZeneca's new San Fran home, Keytruda triumphs again, Novo branches out
A rapid round up from pharma, biotech and healthcare
Digital skills gap hinders UK healthcare innovation
Report calls for greater emphasis on HCPs’ digital and data literacy education
Articles
-
The call for a more strategic medical affairs community How its leaders are stepping up to the plate
-
Transparency and accountability: tackling opacity and blame head-on -
Building trust in our industry -
We can be heroesIs collaboration key?
-
What does ‘digital’ look like for global pharma Learning & Development?
Pharmaceutical Market Europe - May 2018
We start off looking at the newly released 2018 edition of the Drugs to Watch Report, with 12 blockbusters predicted to launch this year. There is hope that some of these new drugs may help patients who are dealing with several of the most unmanageable diseases.
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
The call for a more strategic medical affairs community
How its leaders are stepping up to the plate
Featured jobs
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Scientific Director
-
Great salary and bebefits
-
Associate Director, Healthcare PR
-
£60, 000 – £67, 000+ benefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Senior Medical Writer
-
Great salary and bebefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Assistant Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
-
Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Sales & Marketing Manager - New Launch - Mental Health - S E...
-
Highly Competitive Basic, Bonus &Benefits
Subscribe to our email news alerts
- Novo Nordisk expands cell therapy R&D, says type 1 diabetes cure a step closer
- Novartis, Amgen set low price for first CGRP migraine drug
- FDA starts review of Sanofi’s oral type 1 diabetes drug
- Moving annual total (MAT)
- Key success factor (KSF)
- Immuno-oncology at ASCO: survival data, combinations and new indications
- The call for a more strategic medical affairs community
- Transparency and accountability: tackling opacity and blame head-on
- Beyond the event
- Lucid are bringing magic to the North West with three new hires
- Pfizer drug gets speedy FDA review for rare heart failure complication
- Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- Beyond the event
- ...
- Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
- Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
- Is the pharma business model ready for precision medicine?
- Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
Quick links
Infographics
